Fundrise’s venture fund falls amid concerns about valuation gap
Fundrise Innovation Fund, a publicly traded venture capital fund with stakes in private companies like Anthropic and SpaceX, is coming back down to earth after swelling to more than 25x the value of its assets early this week.
Shares of the fund, which went public on March 19 and uses the ticker VCX, closed at $262 on Thursday and had sunk to $189.26 shortly after market open on Friday. The stock closed at $533 on Wednesday.
The fund is still trading well above its net asset value (NAV), which was $18.26 per share as of March 2, 2026, according to its IPO documents. That means retail investors, desperate for exposure to high-flying private companies but left with no other ways in, are paying a hefty premium.
The gap between its NAV and the stock price led Citron Research to go short on the stock, the firm revealed Thursday.
Ben Miller, Fundrise cofounder and CEO, pushed back on the short report in an interview on CNBC Friday morning, saying his firm can’t control the stock price and noting that pre-IPO investors were actually worried the fund would end up trading at a discount, not a premium.